Navegação por autor "Gotuzzo, Eduardo"
Itens para a visualização no momento 1-20 of 31
-
Antiretroviral therapy and Kaposi's sarcoma trends and outcomes among adults with HIV in Latin America
Castilho, Jessica L. et al. | Data do documento: 2021 -
Ascorbic acid has superior ex vivo antiproliferative, cell death-inducing and immunomodulatory effects over IFN-α in HTLV-1-associated myelopathy.
Moens, Britta et al. | Data do documento: 2012 -
Association between Human T-Cell Lymphotropic Virus Type 1 and 2 (HTLV 1/2) infection and tuberculosis: systematic review and meta-analysis
Arruda, Sérgio Marcos et al. | Data do documento: 2011 -
CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis
Menezes, Soraya Maria et al. | Data do documento: 2014 -
Clinical effects of durability of immunosuppression in virologically suppressed ART-initiating persons with HIV in Latin America. A retrospective cohort study
Caro-Vega, Yanink et al. | Data do documento: 2022 -
Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis
Yamakawa, Natsuko et al. | Data do documento: 2020 -
A decade of HAART in Latin America: Long term outcomes among the first wave of HIV patients to receive combination therapy
Wolff, Marcelo J. et al. | Data do documento: 2017 -
Durability of Efavirenz Compared With Boosted Protease Inhibitor-Based Regimens in Antiretroviral-Naïve Patients in the Caribbean and Central and South America
Caro-Vega, Yanink et al. | Data do documento: 2018 -
Estimated life expectancy gains with antiretroviral therapy among adults with HIV in Latin America and the Caribbean: a multisite retrospective cohort study
Smiley, Casey L. et al. | Data do documento: 2021 -
A FashiLymphoproliferative Phenotype Reveals Non-Apoptotic Fas Signaling in HTLV-1-Associated Neuroinflammation
Menezes, Soraya Maria et al. | Data do documento: 2017 -
Health outcomes among HIV-positive latinos initiating antiretroviral therapy in North America versus Central and South America
Cesar, Carina et al. | Data do documento: 2016 -
Is substance use associated with HIV cascade outcomes in Latin America?
De Boni, Raquel B. et al. | Data do documento: 2018 -
Late-onset opportunistic infections while receiving anti-retroviral therapy in Latin America: burden and risk factors
Núñez, Isaac et al. | Data do documento: 2022 -
Management of HAM/TSP: Systematic Review and Consensus-based Recommendations 2019
Araujo, Abelardo et al. | Data do documento: 2021 -
Monitoring of HIV treatment in seven countries in the WHO Region of the Americas
Belaunzarán-Zamudio, Pablo F et al. | Data do documento: 2015 -
Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean
Carriquiry, Gabriela et al. | Data do documento: 2015 -
New opportunities in tuberculosis prevention: implications for people living with HIV
Fernández, Lucia González et al. | Data do documento: 2020 -
Reducing the global burden of HTLV-1 infection: An agenda for research and action
Willems, Luc et al. | Data do documento: 2017 -
Repurposed antiviral drugs for COVID-19: interim WHO solidarity trial results
Hongchao, Pan et al. | Data do documento: 2020 -
Repurposed antiviral drugs for COVID-19: interim WHO solidarity trial results (Preprint)
Hongchao, Pan et al. | Data do documento: 2020